chr11-6393230-A-G
Variant summary
Our verdict is Pathogenic. Variant got 11 ACMG points: 11P and 0B. PM1PM2PM5PP3_StrongPP5
The NM_000543.5(SMPD1):āc.1106A>Gā(p.Tyr369Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000031 in 1,613,782 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. Y369H) has been classified as Likely pathogenic.
Frequency
Consequence
NM_000543.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 11 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
SMPD1 | NM_000543.5 | c.1106A>G | p.Tyr369Cys | missense_variant | 3/6 | ENST00000342245.9 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
SMPD1 | ENST00000342245.9 | c.1106A>G | p.Tyr369Cys | missense_variant | 3/6 | 1 | NM_000543.5 | P3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152156Hom.: 0 Cov.: 31
GnomAD4 exome AF: 0.00000137 AC: 2AN: 1461626Hom.: 0 Cov.: 31 AF XY: 0.00000138 AC XY: 1AN XY: 727088
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152156Hom.: 0 Cov.: 31 AF XY: 0.0000269 AC XY: 2AN XY: 74338
ClinVar
Submissions by phenotype
Sphingomyelin/cholesterol lipidosis Pathogenic:2
Pathogenic, criteria provided, single submitter | curation | Broad Center for Mendelian Genomics, Broad Institute of MIT and Harvard | Jan 22, 2020 | The p.Tyr369Cys variant in SMPD1 (also known as p.Tyr367Cys due to a difference in cDNA numbering) has been reported in 3 individuals with Niemann-Pick disease, segregated with disease in 2 affected relatives from 1 family (PMID: 19405096, 28801223), and was absent from large population studies. This variant has also been reported in ClinVar (VariationID: 288073) as a VUS by EGL Genetic Diagnostics. In vitro functional studies provide some evidence that the p.Tyr369Cys variant may impact protein function (PMID: 19405096). However, these types of assays may not accurately represent biological function. Computational prediction tools and conservation analyses suggest that this variant may impact the protein, though this information is not predictive enough to determine pathogenicity. The presence of this variant in 2 affected homozygotes and in combination with a reported pathogenic variant in an individual with Niemann-Pick disease increases the likelihood that the p.Tyr369Cys variant is pathogenic (VariationID: 100731; PMID: 19405096, 28801223). The phenotype of an individual homozygous for this variant is highly specific for Niemann-Pick disease based on acid sphingomyelinase activity being <10% of normal, consistent with disease (PMID: 28801223). In summary, this variant meets criteria to be classified as pathogenic for Niemann-Pick disease in an autosomal recessive manner based on in vitro functional studies, the presence of the variant in homozygotes and in combination with other pathogenic variants, and the phenotype of an individual with the variant being highly specific for disease. ACMG/AMP Criteria applied: PS3, PM2, PM3, PP3, PP4 (Richards 2015). - |
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Aug 10, 2023 | Variant summary: SMPD1 c.1106A>G (p.Tyr369Cys) results in a non-conservative amino acid change located in the Calcineurin-like phosphoesterase domain, ApaH type (IPR004843) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 249020 control chromosomes. c.1106A>G has been reported in the literature in multiple individuals affected with Niemann-Pick Disease, including being at a homozygous state or being seen with a second pathogenic variant (example: Rodriguez-Pascau_2009, Mercati_2017, Ranganath_2016, Hu_2021). These data indicate that the variant is very likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in <5% of normal activity (Rodriguez-Pascau_2009). The following publications have been ascertained in the context of this evaluation (PMID: 33675270, 28801223, 27338287, 19405096). Four submitters have cited clinical-significance assessments for this variant to ClinVar after 2014 (Pathogenic n=2, Likely pathogenic n=1, VUS n=1). Based on the evidence outlined above, the variant was classified as pathogenic. - |
Niemann-Pick disease, type A Pathogenic:2
Likely pathogenic, criteria provided, single submitter | research | Diagnostics Division, CENTRE FOR DNA FINGERPRINTING AND DIAGNOSTICS | Apr 25, 2021 | - - |
Likely pathogenic, criteria provided, single submitter | clinical testing | Baylor Genetics | - | - - |
Niemann-Pick disease, type A;C0268243:Niemann-Pick disease, type B Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Invitae | Apr 22, 2023 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense change affects SMPD1 function (PMID: 19405096). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SMPD1 protein function. ClinVar contains an entry for this variant (Variation ID: 288073). This variant is also known as c.1100A>G, p.Y367C. This missense change has been observed in individual(s) with intermediate type Niemann-Pick disease (PMID: 19405096, 27338287, 28801223). It has also been observed to segregate with disease in related individuals. This variant is not present in population databases (gnomAD no frequency). This sequence change replaces tyrosine, which is neutral and polar, with cysteine, which is neutral and slightly polar, at codon 369 of the SMPD1 protein (p.Tyr369Cys). - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | May 24, 2016 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at